Find a Doctor

Dr. Paula Fracasso received her undergraduate degree from the College of the Holy Cross and her medical and graduate degrees from Yale University.  She completed medical residency training at Beth Israel Hospital, postdoctoral training in cancer research at Massachusetts Institute of Technology, and fellowship training in Medical Oncology at Tufts-New England Medical Center. After completing her training, Dr. Fracasso joined the faculty of Washington University in St. Louis where she was Associate Professor in Medicine, Attending Physician at Barnes-Jewish Hospital, and Leader of Developmental Therapeutics at the Alvin J. Siteman Cancer Center. In 2007, she moved to the University of Virginia as Deputy Director of the Cancer Center and Section Chief of Medical Oncology.

Dr. Fracasso specializes in the design and conduct of clinical trials with an emphasis on new drug treatment for women’s cancers. She has served as study chair in over 30 institutional, cooperative group, and pharmaceutical clinical trials. On the national level, Dr. Fracasso is the chair of the Phase I Subcommittee and co-chair of the Developmental Therapeutics Committee in the National Cancer Institute's Gynecologic Oncology Group (GOG) where she is involved in approving and monitoring all Phase I trials for gynecologic malignancies taking place nationwide. She is also a member of NCI's Operational Efficiency Working Group of the Clinical Trials Advisory Committee which has recently proposed changes to reduce the time for activation of NCI-supported clinical trials. She has authored numerous publications and presents nationally on topics related to novel therapies for women's cancers.

Dr. Fracasso's goal is for all women with breast or gynecologic cancers to participate in a clinical trial by designing innovative, personalized therapies in women's cancer care at the University of Virginia Cancer Center.

• Phi Beta Kappa
• Alpha Omega Alpha
• Best Doctors in America
• America’s Top Doctors
• America’s Top Doctors for Cancer